This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2009 Aug;32(8):1556-62.

doi: 10.2337/dc09-0565.

Advances in the medical treatment of diabetic retinopathy

Rafael Simó¹, Cristina Hernández

Affiliations

PMID: 19638526
PMCID: PMC2713619
DOI: 10.2337/dc09-0565

Review

Advances in the medical treatment of diabetic retinopathy

Rafael Simó et al. Diabetes Care. 2009 Aug.

. 2009 Aug;32(8):1556-62.

doi: 10.2337/dc09-0565.

Authors

Rafael Simó¹, Cristina Hernández

Affiliation

¹ CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud CarlosIII, Madrid, Spain. rsimo@ir.vhebron.net

PMID: 19638526
PMCID: PMC2713619
DOI: 10.2337/dc09-0565

No abstract available

PubMed Disclaimer

Similar articles

Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.
Nesto RW. Nesto RW. Am J Cardiovasc Drugs. 2005;5(6):379-87. doi: 10.2165/00129784-200505060-00005. Am J Cardiovasc Drugs. 2005. PMID: 16259526 Review.
[How to treat dyslipidemia in patients with metabolic syndrome].
Soška V. Soška V. Vnitr Lek. 2015 Jul-Aug;61(7-8):721-4. Vnitr Lek. 2015. PMID: 26375703 Czech.
Association of serum lipids with diabetic retinopathy in urban South Indians--the Chennai Urban Rural Epidemiology Study (CURES) Eye Study--2.
Rema M, Srivastava BK, Anitha B, Deepa R, Mohan V. Rema M, et al. Diabet Med. 2006 Sep;23(9):1029-36. doi: 10.1111/j.1464-5491.2006.01890.x. Diabet Med. 2006. PMID: 16922712
The five-year incidence of blindness after introducing a screening programme for early detection of treatable diabetic retinopathy.
Agardh E, Agardh CD, Hansson-Lundblad C. Agardh E, et al. Diabet Med. 1993 Jul;10(6):555-9. doi: 10.1111/j.1464-5491.1993.tb00120.x. Diabet Med. 1993. PMID: 8365093
Fibrates and statins in the treatment of diabetic retinopathy.
Ansquer JC, Crimet D, Foucher C. Ansquer JC, et al. Curr Pharm Biotechnol. 2011 Mar 1;12(3):396-405. doi: 10.2174/138920111794480570. Curr Pharm Biotechnol. 2011. PMID: 20939802 Review.

See all similar articles

Cited by

Fenofibric acid prevents retinal pigment epithelium disruption induced by interleukin-1β by suppressing AMP-activated protein kinase (AMPK) activation.
Villarroel M, Garcia-Ramírez M, Corraliza L, Hernández C, Simó R. Villarroel M, et al. Diabetologia. 2011 Jun;54(6):1543-53. doi: 10.1007/s00125-011-2089-5. Epub 2011 Mar 3. Diabetologia. 2011. PMID: 21369818
Recovery from Diabetic Macular Edema in a Diabetic Patient After Minimal Dose of a Sodium Glucose Co-Transporter 2 Inhibitor.
Yoshizumi H, Ejima T, Nagao T, Wakisaka M. Yoshizumi H, et al. Am J Case Rep. 2018 Apr 19;19:462-466. doi: 10.12659/ajcr.909708. Am J Case Rep. 2018. PMID: 29670074 Free PMC article.
Dietary hyperglycemia, glycemic index and metabolic retinal diseases.
Chiu CJ, Taylor A. Chiu CJ, et al. Prog Retin Eye Res. 2011 Jan;30(1):18-53. doi: 10.1016/j.preteyeres.2010.09.001. Epub 2010 Sep 22. Prog Retin Eye Res. 2011. PMID: 20868767 Free PMC article. Review.
Peroxisome proliferator-activated receptor α protects capillary pericytes in the retina.
Ding L, Cheng R, Hu Y, Takahashi Y, Jenkins AJ, Keech AC, Humphries KM, Gu X, Elliott MH, Xia X, Ma JX. Ding L, et al. Am J Pathol. 2014 Oct;184(10):2709-20. doi: 10.1016/j.ajpath.2014.06.021. Epub 2014 Aug 7. Am J Pathol. 2014. PMID: 25108226 Free PMC article.
Nutrition for diabetic retinopathy: plummeting the inevitable threat of diabetic vision loss.
Sharma Y, Saxena S, Mishra A, Saxena A, Natu SM. Sharma Y, et al. Eur J Nutr. 2017 Sep;56(6):2013-2027. doi: 10.1007/s00394-017-1406-2. Epub 2017 Mar 3. Eur J Nutr. 2017. PMID: 28258307 Review.

See all "Cited by" articles

References

1. Congdon NG, Friedman DS, Lietman T: Important causes of visual impairment in the world today. JAMA 2003; 290: 2057– 2060 - PubMed
1. Lightman S, Towler HM: Diabetic retinopathy. Clin Cornerstone 2003; 5: 12– 21 - PubMed
1. Tong L, Vernon SA, Kiel W, Sung V, Orr GM: Association of macular involvement with proliferative retinopathy in type 2 diabetes. Diabet Med 2001; 18: 388– 394 - PubMed
1. Simó R, Carrasco E, García-Ramírez M, Hernández C: Angiogenic and antiangiogenic factors in proliferative diabetic retinopathy. Curr Diabet Rev 2006; 2: 71– 98 - PubMed
1. Joussen A, Smyth N, Niessen C: Pathophysiology of diabetic macular edema. Dev Ophthalmol 2007; 39: 1– 12 - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information